In July 2024, the FDA approved Kisunla (formerly called Donanemab) which is anti-amyloid clearing treatment which slows cognitive decline by 35% (up to 60% in a separate analysis). Although the FDA rejected Eli Lilly’s request for accelerated approval of the drug in January 2023 since...
Researchers have found that people with 2 copies of the APOE4 gene is more than a risk factor – it is now considered an underlying cause of Alzheimer’s Disease. Prior to the research’s finding published in May, scientists knew the gene APOE4 increased risk. Although...
Jay Leno has filed a petition in a California court to seek conservatorship over his wife, Mavis, who is believed to have Alzheimer’s Disease or some other form of dementia. Leno is seeking conservatorship since Mavis no longer has sufficient mental capacity to do an...
Earlier this year, leqembi (a drug that slows memory decline for those in the early stages of Alzheimer’s Disease by targeting the amyloid protein, usually common with those inflicted with Alzheimer’s as it begins to form) was approved by both FDA and CMS (governmental assistance...
A milestone event in the fight against Alzheimer’s Disease occurred on July 6 when the FDA gave approval for a drug (Leqembi) that not only slows memory loss for those with Alzheimer’s Disease, but it was granted funding approval by the Centers for Medicare &...
Recent research and studies have shown a genetic link between Alzheimer’s Disease and gastrointestinal tract disorders. Although this doesn’t necessarily mean that gut disorders cause Alzheimer’s Disease, it does indicate that people with gut disorders may be at greater risk of developing Alzheimer’s Disease. As...
The FDA has recently approved the medication Aducanumab (which is to be given by infusion every four weeks) that studies have shown to slow the decline of cognitive and functional ability of patients (particularly if in the early stages after a diagnosis or those with...
Unlike the past, you can be anywhere to participate in this year’s Walk to End Alzheimer’s. COVID-19 may have changed how we walk (in the past, it was mass gatherings at different locations throughout the world), but it hasn’t changed the need to walk to raise...
It was recently announced that a simple blood test could be effective in diagnosing Alzheimer’s Disease (even if the person seemed normal) 20 years before memory and thinking problems are to be expected in people with a genetic mutation that causes Alzheimer’s. Although the blood test...
The House of Representatives, with bipartisan support, passed two bills on October 28 that are important to those impacted by Alzheimer’s disease. The Palliative Care and Hospice Education and Training Act (PCHETA) increases the availability and quality of care by creating hospice workforce and palliative...
